George Raptis

2.3k total citations
51 papers, 1.5k citations indexed

About

George Raptis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, George Raptis has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in George Raptis's work include Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Cancer Treatment Studies (8 papers). George Raptis is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Cancer Treatment Studies (8 papers). George Raptis collaborates with scholars based in United States, United Kingdom and Ireland. George Raptis's co-authors include Dawn L. Hershman, Katherine D. Crew, Heather Greenlee, Jillian L. Capodice, Álex de la Sierra, Déborah Fuentes, Lois Brafman, Larry Norton, Clifford A. Hudis and John Crown and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

George Raptis

51 papers receiving 1.4k citations

Peers

George Raptis
Karen L. Koenig United States
Lois Brafman United States
Hisham Hamed United Kingdom
John C. Michalak United States
Jan Feyzi United States
Rosemarie Hanisch United States
Tarit K. Banerjee United States
M. Ellen Warshauer United States
Jennifer R. Klemp United States
Karen L. Koenig United States
George Raptis
Citations per year, relative to George Raptis George Raptis (= 1×) peers Karen L. Koenig

Countries citing papers authored by George Raptis

Since Specialization
Citations

This map shows the geographic impact of George Raptis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Raptis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Raptis more than expected).

Fields of papers citing papers by George Raptis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Raptis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Raptis. The network helps show where George Raptis may publish in the future.

Co-authorship network of co-authors of George Raptis

This figure shows the co-authorship network connecting the top 25 collaborators of George Raptis. A scholar is included among the top collaborators of George Raptis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Raptis. George Raptis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Raptis, George, et al.. (2021). School allergy training promotes internal policy review and enhances staff's preparedness in managing pupils with food allergy. Clinical and Translational Allergy. 11(6). e12042–e12042. 3 indexed citations
3.
Raptis, George, et al.. (2020). A survey of school’s preparedness for managing anaphylaxis in pupils with food allergy. European Journal of Pediatrics. 179(10). 1537–1545. 15 indexed citations
5.
Adelson, Kerin B., Doris Germain, George Raptis, & Noa Biran. (2011). Hormonal Modulation in the Treatment of Breast Cancer. Endocrinology and Metabolism Clinics of North America. 40(3). 519–532. 6 indexed citations
6.
Barginear, Myra F., Mariusz Jaremko, Inga Peter, et al.. (2011). Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score. Clinical Pharmacology & Therapeutics. 90(4). 605–611. 61 indexed citations
7.
Jaremko, Malgorzata, Yumi Kasai, Myra F. Barginear, et al.. (2010). Tamoxifen Metabolite Isomer Separation and Quantification by Liquid Chromatography−Tandem Mass Spectrometry. Analytical Chemistry. 82(24). 10186–10193. 23 indexed citations
8.
Crew, Katherine D., Jillian L. Capodice, Heather Greenlee, et al.. (2007). Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. Journal of Cancer Survivorship. 1(4). 283–291. 70 indexed citations
9.
Crew, Katherine D., Julie M. Campbell, Heather Greenlee, et al.. (2007). High rates of psychosocial stress among Hispanic breast cancer survivors. Journal of Clinical Oncology. 25(18_suppl). 9113–9113. 6 indexed citations
10.
Metafratzi, Zafiria M., A. Georgiadis, Yannis Alamanos, et al.. (2007). Pulmonary involvement in patients with early rheumatoid arthritis. Scandinavian Journal of Rheumatology. 36(5). 338–344. 53 indexed citations
11.
Bovbjerg, Dana H., Guy H. Montgomery, & George Raptis. (2005). Evidence for Classically Conditioned Fatigue Responses in Patients Receiving Chemotherapy Treatment for Breast Cancer. Journal of Behavioral Medicine. 28(3). 231–237. 13 indexed citations
12.
Paciucci, Paolo Alberto, et al.. (2002). Neo-adjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancer. Anti-Cancer Drugs. 13(8). 791–795. 9 indexed citations
13.
Donnelly, Jean, Alice B. Kornblith, Stewart B. Fleishman, et al.. (2000). A pilot study of Interpersonal Psychotherapy by telephone with cancer patients and their partners. Psycho-Oncology. 9(1). 44–56. 102 indexed citations
14.
Hudis, Clifford A., Andrew D. Seidman, José Baselga, et al.. (1998). Lack of Increased Cardiac Toxicity with Sequential Doxorubicin and Paclitaxel. Cancer Investigation. 16(2). 67–71. 9 indexed citations
15.
Hudis, Clifford A., Frankie A. Holmes, Andrew D. Seidman, et al.. (1997). Phase II study of semisynthetic paclitaxel in metastatic breast cancer. European Journal of Cancer. 33(13). 2198–2202. 5 indexed citations
16.
Hudis, C., Andrew D. Seidman, John Crown, et al.. (1996). Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 14(1). 58–65. 127 indexed citations
17.
Raptis, George, et al.. (1996). Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia. American Journal of Hematology. 51(2). 117–121. 7 indexed citations
18.
Crown, John, George Raptis, Nicola Hamilton, et al.. (1995). High-dose chemotherapy of breast cancer: Current status and developmental strategies. European Journal of Cancer. 31(5). 809–811. 4 indexed citations
19.
Vahdat, Linda T., George Raptis, D. Fennelly, & John Crown. (1995). High-Dose Chemotherapy of Metastatic Breast Cancer: A Review. Cancer Investigation. 13(5). 505–510. 2 indexed citations
20.
Esch, Betty C. A. M. van & George Raptis. (1989). [Treatment of decubitus ulcer with Crilanomer and dextranomer].. PubMed. 64(12). 1135–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026